Skip to content

    Kura Oncology (KURA) stock price & financials

    View KURA earnings calls

    Overview

    Price

    Market Cap

    Sector

    Rank

    Performance+61.1% 1Y

    Financials

    Income Statement

    Financial Trajectories

    11
    Quarterly
    MetricQ3 FY24Q4 FY24Q1 FY25Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26Trend
    EarningsRevenue
    $14.11M
    $15.29M
    $20.75M
    $17.34M
    $18.27M
    +29.5%
    $20.87M
    +36.5%
    Strengthening
    Operating Profit
    -$59.88M
    -$22.45M
    -$64.70M
    -$72.67M
    -$80.00M
    -33.6%
    -$86.27M
    -284.2%
    -$78.81M
    -21.8%
    -$73.01M
    -0.5%
    Weakening
    Net Profit
    -$54.40M
    -$19.22M
    -$57.43M
    -$66.12M
    -$74.12M
    -36.2%
    -$81.00M
    -321.5%
    -$73.33M
    -27.7%
    -$68.33M
    -3.3%
    Weakening
    EPS
    $-0.63
    $-0.66
    $-0.75
    $-0.85
    -34.9%
    $-0.83
    -25.8%
    $-0.77
    -2.7%
    Weakening
    Other Income
    $5.48M
    $5.26M
    $7.50M
    $6.54M
    $5.88M
    +7.3%
    $5.34M
    +1.6%
    $5.49M
    -26.8%
    $4.69M
    -28.4%
    Weakening
    Interest
    $412.0K
    $403.0K
    $382.0K
    $391.0K
    $393.0K
    -4.6%
    $346.0K
    -14.1%
    $336.0K
    -12.0%
    $345.0K
    -11.8%
    Weakening
    Depreciation
    Profit before Tax
    -$54.40M
    -$17.20M
    -$57.20M
    -$66.12M
    -$74.12M
    -36.2%
    -$80.93M
    -370.5%
    -$73.33M
    -28.2%
    -$68.32M
    -3.3%
    Weakening
    MarginsOPM
    -458.6%
    -475.3%
    -385.5%
    -497.6%
    -431.5%
    +5.9%
    -349.8%
    +26.4%
    Strengthening
    Tax
    -0.4%
    -0.0%
    +97.5%
    -0.0%
    Strengthening
    ReturnsROIC
    4.1%
    1.5%
    4.4%
    5.0%
    5.6%
    +36.2%
    6.2%
    +321.5%
    5.6%
    +27.7%
    5.2%
    +3.3%
    Strengthening

    Balance Sheet

    Balance Sheet

    USD · Annual
    Line itemFY18FY19FY20FY21FY22FY23FY24FY25TTM
    AssetsCash & Equivalents$16.12M$26.14M$325.49M$90.67M$51.80M$37.32M$224.46M$149.10M$70.24M
    Short-Term Investments
    Total Current Assets$181.20M$239.60M$637.29M$522.29M$446.43M$432.48M$744.83M$708.66M$559.44M
    Net PP&E$278.0K$8.36M$8.25M$6.38M$8.85M$7.49M$15.16M$14.62M
    Goodwill
    Intangibles
    Total Assets$182.38M$241.97M$647.21M$534.05M$456.31M$448.94M$760.16M$738.36M$587.79M
    LiabilitiesTotal Current Liabilities$13.62M$15.56M$26.02M$22.45M$24.06M$35.26M$78.71M$116.97M$118.19M
    Short-Term Debt$250.0K$3.00M$2.61M$0$4.22M
    Long-Term Debt$7.50M$7.25M$4.25M$9.16M$9.33M$6.92M$9.71M$5.57M
    Long-Term Leases$5.64M$4.61M$2.55M$6.36M$5.19M$9.47M$13.37M
    Total Liabilities$21.39M$23.19M$36.31M$27.44M$36.03M$51.66M$346.52M$564.23M$539.36M
    EquityCommon Stock & APIC$4.0K$5.0K$7.0K$7.0K$7.0K$7.0K$8.0K$9.0K$9.0K
    Retained Earnings-$149.74M-$212.88M-$302.50M-$432.97M-$568.81M-$721.44M-$895.42M-$1.17B-$1.32B
    Total Equity$160.99M$218.78M$610.90M$506.61M$420.28M$397.27M$413.64M$174.13M$48.43M
    HighlightsNet Cash / (Debt)$18.64M$318.24M$214.94M$139.39M$60.45M

    Cash Flow

    Cash Flow

    USD · Annual
    Line itemFY18FY19FY20FY21FY22FY23FY24FY25TTM
    ActivitiesCash from Operating-$48.66M-$54.76M-$69.83M-$104.55M-$110.06M-$124.82M$134.32M-$64.06M-$111.76M
    Cash from Investing-$79.30M-$46.33M-$99.94M-$126.83M$32.63M$15.56M-$101.59M-$13.10M$97.35M
    Cash from Financing$132.64M$111.10M$469.33M-$3.44M$38.56M$94.78M$154.42M$1.79M$2.70M
    SummaryCapital Expenditure-$2.17M-$1.15M-$626.0K-$168.0K-$472.0K-$6.64M-$5.67M
    Free Cash Flow-$72.00M-$105.70M-$110.69M-$124.99M$133.84M-$70.70M-$117.43M
    FCF Margin248.4%-104.8%-152.1%

    Ratios